When a bioprocess shifts, can your team trace the evidence behind what happens next?
Marc Smith of IDBS follows a CMC investigation from multi-batch data and risk assessment through DoE and process updates.
馃搮 Nov 13, 16:30 GMT
馃敆 eu1.hubs.ly/H0zGzDT0
Marc Smith of IDBS follows a CMC investigation from multi-batch data and risk assessment through DoE and process updates.
馃搮 Nov 13, 16:30 GMT
馃敆 eu1.hubs.ly/H0zGzDT0